Natera, Inc.
$206.77
$4.79(-2.26%)
Natera, Inc.
NTRA
$206.77
$4.79(-2.26%)
Natera, Inc.
NTRA
NASDAQ
$206.77
$4.79(-2.26%)
Chart
Upcoming Earnings
Next report date
May 7, 2026
Report period
Q2 2026
EPS Estimate
$-0.53
Revenue Estimate
$616.99M
Key stats
52-Week Range$206.77
$131.81
$256.36
Market capitalization
$29.31BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
-136.14Basic EPS (TTM)
$-1.53Net income (TTM)
$-208.16MRevenue (TTM)
$2.31BAvg. volume
1.23MBeta (1Y)
1.68Employees
4.42KMarket capitalization
$29.31BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
-136.14Basic EPS (TTM)
$-1.53Net income (TTM)
$-208.16MRevenue (TTM)
$2.31BAvg. volume
1.23MBeta (1Y)
1.68Employees
4.42KScreener Quick Check
Sign in to check this stock against your screeners
Sign InAbout Natera, Inc.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Steven Leonard Chapman
Website
www.natera.comHeadquarters
13011 McCallen Pass Building A, Austin, CA, 78753
IPO Date
2015-07-01
Identifiers
ISIN
US6323071042Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a...
Related Stocks
$35.86
1D:
1.4%
1Y:
118.8%
US8816242098Healthcare
Mkt Cap
$41.76B
P/E Ratio TTM
25.7
Revenue TTM
$17.26B
Beta
0.86
Earnings TTM
$1.41B
Dividend Yield TTM
0.00%
$176.42
1D:
9.6%
1Y:
15.8%
US46266C1053Healthcare
Mkt Cap
$29.94B
P/E Ratio TTM
19.7
Revenue TTM
$16.31B
Beta
1.39
Earnings TTM
$1.36B
Dividend Yield TTM
0.00%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q2 '26
Actual
Estimate